Khamira Banafsha for the symptomatic treatment of Covid-19 Disease

Authors

  • Mohammad Zakir Assistant Professor, Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for skin Disorders (NRIUMSD), Hyderabad, India
  • Mohd Naushad Assistant Professor, Department of Ilmul Advia (Pharmacology), Uttranchal Unani Medical College & Hospital, Mustafabad (Padratha), Haridwar, India
  • Wasim Ahmad Assistant Professor, Department of Kulliyyat-e-Tibb, National Institute of Unani Medicine (NIUM), Bangalore, India
  • Tasleem Ahmad Research Officer, Department of Biochemistry, National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad, India
  • Syeda Hajra Fatima Research Officer, Department of Pathology, National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad, India
  • Md Aftab Alam Department of Ilmul Advia (Pharmacology), National Research Institute of Unani Medicine for Skin Disorders (NRIUMSD), Hyderabad, India
  • Ghazala Javed Research Officer, Central Council for Research in Unani Medicine, New Delhi, India

DOI:

https://doi.org/10.3329/bjms.v21i4.60262

Keywords:

Antiviral, Antipyretic; Covid-19; Herbal medicine; Khamira Banafsha; Repurposing; Respiratory diseases; Unani medicine

Abstract

Respiratory illness is one of the most important public health problems in many countries worldwide. Even though most of the ailments are treatable with normal care, respiratory-related mortality continues to increase year after year. The global situation is deteriorating as a result of the COVID-19 epidemic. Numerous Unani formulations are beneficial against a variety of respiratory disorders, but they must be clinically researched before they can obtain widespread acceptance in the modern world. At the moment, no antiviral medication is either available for each respiratory disease or is costly and not easy to use in pandemics like COVID-19 on large scale, although Unani medicines may be considered an option. Khamira Banafsha (KB) is a semi-solid blend of three dried flowers, Viola odorata L., Borago officinalis L., and Rosa damascena Mill and the distillate of Rosa damascena, and sugar. The components in this formulation are well-known and frequently utilized in the treatment of respiratory problems.The formulation has been used to treat a wide range of illnesses for decades. This review will discuss the pharmacology, ethnopharmacology, and repurposing of KB as an adjuvant or symptomatic treatment for Covid-19 illness.The chemical composition of the ingredients may be evaluated In-silico to identify their eligibility for Covid-19 disease symptomatic management.

Bangladesh Journal of Medical Science Vol. 21 No. 04 October’22 Page : 883-892

Downloads

Download data is not yet available.
Abstract
310
PDF
391

Downloads

Published

2022-09-11

How to Cite

Zakir, M. ., Naushad, M. ., Ahmad, W. ., Ahmad, T. ., Fatima, S. H. ., Alam, M. A. ., & Javed, G. . (2022). Khamira Banafsha for the symptomatic treatment of Covid-19 Disease. Bangladesh Journal of Medical Science, 21(4), 883–892. https://doi.org/10.3329/bjms.v21i4.60262

Issue

Section

Original Articles